Biological E seeks DCGI’s nod for phase-III trial of Corbevax as booster dose in those vaccinated with Covishield or Covaxin Read more
DCGI gives nod for Biological E’s COVID-19 vaccine’s phase-II/III trials on kids aged between five and 18 Read more